The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 06, 2016

Filed:

Feb. 21, 2013
Applicant:

Children's Hospital Medical Center, Cincinnati, OH (US);

Inventor:

Yi Zheng, Cincinnati, OH (US);

Assignee:

Children's Hospital Medical Center, Cincinnati, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/04 (2006.01); A61K 39/00 (2006.01); A61K 38/45 (2006.01); A61K 31/403 (2006.01); A61K 38/19 (2006.01); A61K 45/06 (2006.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01); A61K 31/395 (2006.01); A61K 38/16 (2006.01); A61K 38/18 (2006.01); A61K 38/20 (2006.01); A61K 38/44 (2006.01);
U.S. Cl.
CPC ...
A61K 38/45 (2013.01); A61K 31/395 (2013.01); A61K 31/403 (2013.01); A61K 38/16 (2013.01); A61K 38/18 (2013.01); A61K 38/193 (2013.01); A61K 38/202 (2013.01); A61K 38/204 (2013.01); A61K 38/2073 (2013.01); A61K 38/44 (2013.01); A61K 45/06 (2013.01); G01N 33/5011 (2013.01); G01N 33/56966 (2013.01); G01N 2333/70596 (2013.01);
Abstract

Methods, processes, uses, and pharmaceutical compositions are provided herein for mobilizing hematopoietic progenitor cells and/or cancer stem cells from bone marrow into peripheral blood, comprising the administration of an effective amount of an inhibitor of GTPases, such as a Cdc-42 specific inhibitor alone or in combination with one or more additional agents. Specifically, methods are disclosed for mobilizing hematopoietic stem cells into a subject's peripheral blood. In particular, embodiments of the method involve specific inhibition of the Cdc42 GTPase to increase the numbers of hematopoietic stem cells into a subject's peripheral blood of a subject.


Find Patent Forward Citations

Loading…